Cannabinoid Receptors

Cannabinoid receptor agonists, antagonists and inverse agonists act on the CB1 and CB2 receptors. Cannabinoid receptor 1 (CB1) was cloned from rat brain in 1990 and shown to be a G protein-coupled receptor. Cannabinoid receptor 2 (CB2) followed in 1993 as a peripheral receptor found in immune cells and tissues such as spleen. CB1 is abundant in the central nervous system, so the two subtypes are studied in neuroscience and immunology. WIN 55,212-2 mesylate activates both receptors, while AM251 blocks CB1 and AM630 blocks CB2. PF-3845 inhibits fatty acid amide hydrolase (FAAH), the enzyme that breaks down fatty acid amide endocannabinoids.

21 Items

  • SR 144528
    Cat. No.
    A12376

    SR 144528

    SR 144528 is a selective peripheral cannabinoid receptor inverse agonist that displays a Ki value of 0.6 nM for rat spleen and human recombinant CB2 receptors and a Ki value of 400 nM for rat brain and human recombinant CB1 receptors.

    1 mg
    $30.00
    5 mg
    $80.00
    All 7 sizes
  • Taranabant
    Cat. No.
    A11578

    Taranabant

    Synonyms: MK-0364

    Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist that inhibits the binding and functional activity of various agonists, with a binding Ki of 0.13 nM for the human CB1R in vitro.

    1 mg
    $90.00
    2 mg
    $120.00
    All 6 sizes
  • BML-190
    Cat. No.
    A11938

    BML-190

    BML-190 is a selective inverse agonist of the human cannabinoid CB2 receptor.

    5 mg
    $25.00
    10 mg
    $30.00
    All 8 sizes
  • CB2R-IN-1
    Cat. No.
    A12306

    CB2R-IN-1

    CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 0.9 nM.

    1 mg
    $180.00
    5 mg
    $650.00
    All 6 sizes
  • Taranabant ((1R,2R)stereoisomer)
    Cat. No.
    A21705

    Taranabant ((1R,2R)stereoisomer)

    Synonyms: MK0364 (1R,2R)stereoisomer; MK 0364

    Taranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant. Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist.

    2 mg
    $155.00
    5 mg
    $315.00
    All 6 sizes
  • CB1 antagonist 4
    Cat. No.
    A59196

    CB1 antagonist 4

    CB1 antagonist 4 is a selective inverse agonist for the cannabinoid receptor 1 (CB1), demonstrating an IC50 of 8.5 nM in human CB1 assays. This compound exhibits a notable selectivity for CB1 over CB2 receptors, with an IC50 of 604.9 nM. CB1 antagonist 4 effectively inhibits GTP binding in CB1-overexpressing cell membranes, with an EC50 of 18.5 nM, making it a valuable tool for studying CB1 receptor biology and signaling pathways.

    2 mg
    $35.00
    5 mg
    $80.00
    All 7 sizes
  • SCH 336
    Cat. No.
    A59202

    SCH 336

    Synonyms: SCH-225336

    SCH 336 is a potent and selective inverse agonist of the CB2 receptor. It has been shown to inhibit the migration of BaF3 cells expressing CB2, as well as significantly reduce leukocyte migration in vivo. Additionally, SCH 336 effectively blocks ovalbumin-induced eosinophilia in mouse models, making it a valuable tool for research into inflammation and immune response modulation.

    5 mg
    $35.00
    10 mg
    $60.00
    All 6 sizes
  • CB1 inverse agonist 2
    Cat. No.
    A59203

    CB1 inverse agonist 2

    CB1 inverse agonist 2 is a potent orally active inverse agonist targeting the Cannabinoid Receptor CB1. This compound effectively inhibits CP55940-induced hypothermia and anorexia in mouse models, making it a valuable tool for studying cannabinoid receptor-mediated pathways. Its ability to modulate CB1 receptor activity positions it as a significant reagent for research in neuropharmacology and metabolic disorders.

    5 mg
    $170.00
    10 mg
    $285.00
    All 5 sizes
  • Hemopressin (human, mouse)
    Cat. No.
    A59208

    Hemopressin (human, mouse)

    Hemopressin (human, mouse) is a nonapeptide that functions as an inverse agonist of the CB1 cannabinoid receptors. Originally derived from the α1-chain of hemoglobin and isolated from rat brain homogenates, Hemopressin is orally active and exhibits selective antagonistic properties. This compound demonstrates significant antinociceptive effects in models of inflammatory pain, making it a valuable tool for research into pain mechanisms and cannabinoid receptor biology.

    1 mg
    $45.00
    5 mg
    $115.00
    All 3 sizes
  • Hemopressin(rat)
    Cat. No.
    A59214

    Hemopressin(rat)

    Hemopressin (rat) is a nonapeptide derived from the α1-chain of hemoglobin, known for its role as a selective inverse agonist of the CB1 cannabinoid receptors. This compound demonstrates antinociceptive effects in various inflammatory pain models, making it a valuable tool for research on pain mechanisms and cannabinoid signaling. Its oral bioactivity enhances its utility in in vivo studies within the field of cannabinoid pharmacology.

    1 mg
    $25.00
    5 mg
    $50.00
    All 3 sizes
  • MDA77
    Cat. No.
    A59272

    MDA77

    MDA77 is an inverse agonist of the CB2 receptor, exhibiting a potent EC50 of 5.82 nM. This compound demonstrates selectivity for the human CB2 receptor while showing no activity on the CB1 receptor. MDA77 is suitable for research applications investigating cannabinoid-related signaling pathways and their therapeutic potential in various conditions.

    5 mg
    $240.00
    10 mg
    $395.00
    All 4 sizes
  • SMM-189
    Cat. No.
    A59284

    SMM-189

    SMM-189 is a potent and selective inverse agonist of the cannabinoid receptor 2 (CB2). This compound demonstrates significant biological activity relevant to the modulation of inflammatory and neuroprotective pathways, making it a valuable tool in the investigation of neurodegenerative disorders and traumatic brain injury. Its selective targeting of the CB2 receptor provides insights into therapeutic approaches for conditions associated with these pathologies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Hemopressin(human, mouse) TFA
    Cat. No.
    A59301

    Hemopressin(human, mouse) TFA

    Hemopressin (human, mouse) TFA targets the cannabinoid CB1 receptor as a selective inverse agonist. This nonapeptide, derived from the α1-chain of hemoglobin and originally isolated from rat brain homogenates, demonstrates oral bioavailability. Hemopressin TFA has been shown to exert antinociceptive effects in models of inflammatory pain, making it valuable for research in pain management and cannabinoid signaling pathways.

    Out of stock

    All 3 sizes
  • TC-C 14G
    Cat. No.
    A59312

    TC-C 14G

    TC-C 14G is a potent inverse agonist of the Cannabinoid-1 Receptor (CB1R), exhibiting a Ki value of 4 nM and an EC50 of 11 nM for HCB1R. This compound is valuable for research exploring the role of CB1R in various physiological processes and the pathophysiology of diseases related to cannabinoid signaling. Its efficacy in modulating CB1R activity makes it a significant tool for studies focused on neurobiology, appetite regulation, and potential therapeutic interventions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • CB1R antagonist 1
    Cat. No.
    A59315

    CB1R antagonist 1

    CB1R Antagonist 1 is a selective inverse agonist of the cannabinoid-1 receptor (CB1R) with an IC50 value of 4.2 μM. This compound effectively modulates CB1R activity, making it a valuable tool for investigating metabolic processes and obesity-related pathways. Its specificity and potency facilitate research into the therapeutic potential of targeting CB1R in metabolic disorders.

    5 mg
    $55.00
    10 mg
    $100.00
    All 5 sizes
  • MK-5596
    Cat. No.
    A59320

    MK-5596

    MK-5596 is a selective and orally active inverse agonist of the cannabinoid receptor 1 (CB1R), exhibiting an IC50 of 1.0 nM and an EC50 of 5.8 nM. This compound demonstrates significant biological activity in promoting weight loss and appetite suppression. Additionally, MK-5596 exhibits mild inhibitory effects on several cytochrome P450 enzymes, including CYP3A4, CYP2C8, CYP2C9, and CYP2D6, with IC50 values ranging from 3.3 to 18 μM. This reagent is primarily utilized in research focused on obesity and its associated metabolic disorders.

    Out of stock

    All 3 sizes
  • TM38837
    Cat. No.
    A59332

    TM38837

    TM38837 is a selective inverse agonist targeting cannabinoid receptor 1 (CB1), exhibiting an IC50 of 24 nM. With a significantly higher selectivity for CB1 over cannabinoid receptor 2 (CB2) (IC50: 4500 nM), TM38837 demonstrates potential in modulating metabolic processes. Its biological activity includes reducing body weight and improving plasma inflammatory markers and glucose homeostasis, making it a valuable tool for research on metabolic disorders and obesity.

    2 mg
    $35.00
    5 mg
    $80.00
    All 7 sizes
  • COR170
    Cat. No.
    A59353

    COR170

    COR170 is a selective inverse agonist of the CB2 receptor, identified as a 4-quinolone-3-carboxylic acid derivative with a Ki value of 3.8 nM. This compound has shown potential in modulating inflammatory responses and provides insights into neuroprotective mechanisms. It is valuable for research applications focused on understanding the role of CB2 receptors in various biological processes related to inflammation and neuroprotection.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Hemopressin(rat) TFA
    Cat. No.
    A59362

    Hemopressin(rat) TFA

    Hemopressin (rat) TFA is a nonapeptide derived from the α1-chain of hemoglobin, with its origins traced to rat brain homogenates. This compound serves as a selective inverse agonist of CB1 cannabinoid receptors, demonstrating oral bioactivity. Hemopressin (rat) TFA exhibits significant antinociceptive effects in models of inflammatory pain, making it a valuable tool for research in pain modulation and cannabinoid receptor biology.

    Out of stock

    All 3 sizes
  • MRL-650
    Cat. No.
    A59466

    MRL-650

    Synonyms: CB1 inverse agonist 1

    MRL-650 is a potent inverse agonist of the CB1 receptor, exhibiting an IC50 of 7.5 nM for CB1, while maintaining a significantly lower affinity for the CB2 receptor at 4100 nM. This compound is orally active and is primarily utilized in research focused on anorexigenic effects. Its selectivity and potency make MRL-650 a valuable tool for investigating the physiological and pharmacological roles of the endocannabinoid system.

    1 mg
    $40.00
    5 mg
    $95.00
    All 7 sizes

21 Items

Added to your cart

View Cart Checkout

    Loading...